---
title: "Oruka Therapeutics Surges 10% During Regular Trading on Analyst Upgrades"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293069381.md"
description: "Oruka Therapeutics jumps 10% on analyst upgrades; TD Cowen keeps Buy rating with $150 target on strong pipeline."
datetime: "2026-07-17T19:40:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293069381.md)
  - [en](https://longbridge.com/en/news/293069381.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293069381.md)
---

# Oruka Therapeutics Surges 10% During Regular Trading on Analyst Upgrades

Oruka Therapeutics(ORKA.US) 盘中涨**9.91%**，现报**91.27 美元**。

公司股价受分析师上调评级推动，多份研报指出其医疗赛道上行潜力。近期 TD Cowen 维持「买入」评级，目标价 150 美元，称其核心管线 ORKA-001 在银屑病治疗中展现**64% PASI 100**响应率，现金储备**12 亿美元**支撑后续研发。此外，Halozyme 合作引入 Hypercon 注射技术亦构成利好因素。

### Related Stocks

- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)

## Related News & Research

- [Oruka Therapeutics CMO Joana Goncalves disposes of 7,000 common shares for $601,227.73](https://longbridge.com/en/news/292825802.md)
- [Oruka Therapeutics SVP Finance Arjun Agarwal sells USD 840,975 in common shares](https://longbridge.com/en/news/292532295.md)
- [Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares](https://longbridge.com/en/news/291509634.md)
- [Oruka Therapeutics COO Laura Lee Sandler sells USD 472,784 in common shares](https://longbridge.com/en/news/291472174.md)
- [Oruka Advances EVERLAST-A Plaque Psoriasis Trial Data; Stock Jumps Over 20%](https://longbridge.com/en/news/279067007.md)